NCT04378686View on ClinicalTrials.gov

Serological Testing for COVID-19 (SARS-CoV-2) in ESKD

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

December 12, 2022

Study Completion Date

December 12, 2022

Conditions
SARS-CoV 2End Stage Renal Failure on Dialysis
Interventions
OTHER

dialysis

treatment with dialysis. This can be hemodialysis, hemodiafiltration, peritoneal dialysis

Trial Locations (3)

3000

University Hospitals Leuven, Leuven

3500

Jessa Ziekenhuis, Hasselt

3800

Sint Trudo, Sint-Truiden

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04378686 - Serological Testing for COVID-19 (SARS-CoV-2) in ESKD | Biotech Hunter | Biotech Hunter